P{lacW}Cct116919 is inserted in the first intron of Cct1.
ommatidium (with Df(3L)Ar14-8)
ommatidium (with Pcyt1EP831)
Cct116919 mutants contain large lipid droplets in the fat body. However, salivary glands of these mutants do not show ectopic lipid storage.
When eggs are laid by mutant females a collapsed egg phenotype is sometimes seen.
Cct116919 and Cct116919/Df(3L)Ar14-8 mutants eclose a few days later than wild type. Cct116919 mutants display a mild rough eye phenotype, while Cct116919/Df(3L)Ar14-8 mutants have a more penetrant rough eye phenotype. Such eyes have defects in ommatidial polarity (chirality defects and misrotations) and suffer a loss of photoreceptor cells; quantification of these defects reveals higher numbers in Cct116919/Df(3L)Ar14-8 mutants than Cct116919 mutants. Cct116919/Cct1EP831 transheterozygotes display a milder rough eye phenotype than Cct116919 homozygotes, with fewer defects scored. Additionally, Cct116919 female mutants lay few eggs and Cct116919/Df(3L)Ar14-8 female mutants lay no eggs, causing sterility in both cases. Mitotic Cct116919 clones in third larval instar eye discs show defects in tissue polarity due to aberrant ommatidial rotation and defects in cell fate selection of the R3/R4 photoreceptor pair leading to abnormal ommatidial chirality.
Pcyt116919 has abnormal planar polarity phenotype, enhanceable by aosΔ7/argos[+]/N[+]/N55e11
Pcyt116919 has abnormal planar polarity phenotype, non-enhanceable by aosΔ7/argos[+]
Pcyt116919 has abnormal planar polarity phenotype, non-enhanceable by argos[+]/aosW11/N[+]/N55e11
Pcyt116919 has female sterile phenotype, non-suppressible by iPLA2-VIAΔ23/iPLA2-VIAΔ23
Pcyt116919 has male semi-sterile phenotype, non-suppressible by iPLA2-VIAΔ23/iPLA2-VIAΔ23
Pcyt116919 has partially lethal phenotype, non-suppressible by iPLA2-VIAΔ23/iPLA2-VIAΔ23
Pcyt116919 has eye photoreceptor cell phenotype, enhanceable by aosΔ7/argos[+]/N[+]/N55e11
Pcyt116919 has ommatidium phenotype, enhanceable by aosΔ7/argos[+]/N[+]/N55e11
Pcyt116919 has eye phenotype, enhanceable by N[+]/N55e11
Pcyt116919 has eye photoreceptor cell phenotype, non-enhanceable by aosΔ7/argos[+]
Pcyt116919 has ommatidium phenotype, non-enhanceable by aosΔ7/argos[+]
Pcyt116919 has eye photoreceptor cell phenotype, non-enhanceable by argos[+]/aosW11/N[+]/N55e11
Pcyt116919 has ommatidium phenotype, non-enhanceable by argos[+]/aosW11/N[+]/N55e11
Pcyt116919/Cct1[+] is an enhancer of wing phenotype of N55e11
Pcyt116919/Cct1[+] is a suppressor of crossvein | increased number phenotype of EgfrE3
Pcyt116919/Cct1[+] is a suppressor of eye photoreceptor cell phenotype of EgfrE3
EgfrE3/+, Cct116919/+ double mutants show reduced loss of photoreceptors in the eye, a more regular arrangement of ommatidia and a reduction in the presence of extra crossveins in the wing compared to EgfrE3/+ single mutants. The Cct116919 allele dominantly enhances the notched wing phenotype seen in N55e11/+ flies. While Cct116919/+, argosΔ7/+ double heterozygotes have no eye defects, N55e11/+; Cct116919/+, argosΔ7/+ triple heterozygotes show an enhancement in the defective eye phenotype (loss of photoreceptor cells, defects in ommatidial polarity and chirality and a partial loss of the ventral eye) seen in Cct116919 mutants. This phenotype is not significantly enhanced in N55e11/+; Cct116919/+, argosW11/+ triple heterozygotes. The Cct116919 homozygous phenotype is strongly enhanced in N55e11/+ background mutants causing severely reduced eyes.
Pcyt116919 is rescued by Pcyt1+t11.2
Isolated in screen described in FBrf0083893.